{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[
        "24345752",
        "22760778"
      ],
      "tumorType":{
        "children":{},
        "code":"AITL",
        "color":"LimeGreen",
        "id":264,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature T and NK Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Angioimmunoblastic T-Cell Lymphoma",
        "parent":"MTNN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx2",
      "pmids":[
        "26771811",
        "20693430",
        "22919025",
        "27662201",
        "24695057",
        "21828135"
      ],
      "tumorType":{
        "children":{},
        "code":"CMML",
        "color":"LightSalmon",
        "id":224,
        "level":4,
        "mainType":{
          "id":null,
          "name":"Myelodysplastic/Myeloproliferative Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Chronic Myelomonocytic Leukemia",
        "parent":"MDS/MPN",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx2",
      "pmids":[
        "24030381",
        "21714648",
        "25465125",
        "24220272"
      ],
      "tumorType":{
        "children":{},
        "code":"MDS",
        "color":"LightSalmon",
        "id":355,
        "level":3,
        "mainType":{
          "id":null,
          "name":"Myelodysplastic Syndromes",
          "tumorForm":"LIQUID"
        },
        "name":"Myelodysplastic Syndromes",
        "parent":"MNM",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"TET2, a tumor suppressor and DNA demethylase, is frequently mutated in hematologic malignancies.",
  "highestDiagnosticImplicationLevel":"LEVEL_Dx2",
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"10/22/2018",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "24315485",
        "21057493"
      ]
    },
    "description":"Truncating mutations of TET2 disrupt the C-terminal catalytic domain of the protein, predicted to cause gene inactivation and are considered oncogenic events (PMID: 21057493, 24315485). Consequently, these alterations abrogate TET2 enzymatic function to generate 5-hydroxymethylcytosine (5-hmC) (PMID: 21057493).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"P472Lfs*14",
    "alterationType":null,
    "consequence":"frameshift_variant",
    "entrezGeneId":54790,
    "hgvs":"4:g.105235355del",
    "hugoSymbol":"TET2",
    "id":null,
    "proteinEnd":471,
    "proteinStart":471,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The TET2 P472Lfs*14 mutation is likely oncogenic.",
  "vus":false
}